bullish

Ainos

Ainos, Inc.- Signed Veldona Partner for Manufacturing and Taiwan Marketing of Sjogren's Drug

204 Views04 Dec 2024 19:35
Issuer-paid
Key regional partner for Veldona; a good start for Ainos’ out-licensing strategy. Ainos entered a strategic partnership with Taiwan Tanabe Seiyaku for Veldona in Sjogren’s syndrome.
What is covered in the Full Insight:
  • Introduction to Veldona and Ainos' Strategy
  • Partnership with Taiwan Tanabe Seiyaku
  • Clinical Trial Updates
  • Market Outlook for Sjogren's Syndrome Treatment
  • Prior Clinical Study Results for Veldona
SUMMARY
(Sign Up to Access)
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
  • Unlock research summaries
  • Follow top, independent analysts
  • Receive personalised alerts
  • Access Analytics, Events and more

Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.

Upgrade later to our paid plans for full-access.

or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 5-minute read)
Discussions
(Paid Plans Only)
chart-bar
Logo
Water Tower Research
Research from Water Tower Research
Water Tower Research
Equity Bottom-UpThematic (Sector/Industry)
Price Chart(Sign Up to Access)
analytics-chart
  • Loading...
x